FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Holodniy

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1
HIV

Physiology

Procedures

Co-author Network

Publications

TOP 3
Patricia L Schirmer; Danielle Stanek; Stephen R Benoit; Achintya Dey; Cynthia A Lucero-Obusan; Mirsonia Martinez; Gina Oda; Luis M Santiago; Mark Holodniy
Dengue surveillance in Veterans Affairs healthcare facilities, 2007-2010.
Lauren E Kushner; Laura C Lazzeroni; Anu Osinusi; Michael A Polis; Aaron M Wendelboe; Mark A Winters; Aarthi Chary; Shyam Kottilil; Mark Holodniy
Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients.
Clay Bavinger; Eran Bendavid; Mark Holodniy; Nanjiang Hou; Katherine Niehaus; Ingram Olkin; Richard A Olshen; Douglas K Owens; Vandana Sundaram; Nicole Wein; Manisha Desai
Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Holodniy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Patricia L Schirmer; Danielle Stanek; Stephen R Benoit; Achintya Dey; Cynthia A Lucero-Obusan; Mirsonia Martinez; Gina Oda; Luis M Santiago; Mark Holodniy
Dengue surveillance in Veterans Affairs healthcare facilities, 2007-2010.
PLoS neglected tropical diseases 2013;7(3):e2040.
2013: Lauren E Kushner; Laura C Lazzeroni; Anu Osinusi; Michael A Polis; Aaron M Wendelboe; Mark A Winters; Aarthi Chary; Shyam Kottilil; Mark Holodniy
Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients.
PloS one 2013;8(4):e60387.
2013: Clay Bavinger; Eran Bendavid; Mark Holodniy; Nanjiang Hou; Katherine Niehaus; Ingram Olkin; Richard A Olshen; Douglas K Owens; Vandana Sundaram; Nicole Wein; Manisha Desai
Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review.
PloS one 2013;8(3):e59551.
2013: Shan Liu; Mark Holodniy; Lauren E Cipriano; Jeremy D Goldhaber-Fiebert
Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States.
PloS one 2013;8(3):e58975.
2012: Anu Osinusi; Michael A Polis; Mark A Winters; Aarthi Chary; Shyam Kottilil; Henry Masur; Susanna Naggie; Mark Holodniy
IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.
Journal of medical virology 2012;84(10):1522-7.
2012: Mark Holodniy; Yury E Khudyakov; Yulin Lin; Cynthia A Lucero; Gina Oda; Patricia L Schirmer; Ronald Valdiserri; Guoliang Xia; Victoria J Davey; William E Duncan; Gerald M Cross
Results from a large-scale epidemiologic look-back investigation of improperly reprocessed endoscopy equipment.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2012;33(7):649-56.
2012: Patricia L Schirmer; Cynthia A Lucero; Renee C Mercier; Nancy Nguyen; Gina Oda; Russell A Ryono; Mark Holodniy
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2012;33(4):409-11.
2012: Jodie A Trafton; Ann Combs; Mark Holodniy; Percy Link; Heather Pierson; John T Sorrell; Dennis Israelski
Outcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics.
The journal of behavioral health services & research 2012;39(2):158-73.
2012: Aarthi Chary; Robert Eisen; Thomas H Knight; Mark A Winters; David M Asmuth; Mark Holodniy
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Journal of medical virology 2012;84(3):431-7.
2012: Shan Liu; Douglas K Owens; Lauren E Cipriano; Mark Holodniy; Jeremy D Goldhaber-Fiebert
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.
Annals of internal medicine 2012;156(4):279-90.
2012: Lauren E Cipriano; Mark Holodniy; Douglas K Owens; Gregory S Zaric; Eran Bendavid; Margaret L Brandeau
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.
PloS one 2012;7(9):e45176.
2012: Mark A Winters; Michael J Kozal; Robert M Lloyd; Michael D Miller; Robert W Shafer; Mark Holodniy
Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.
PloS one 2012;7(7):e40514.
2012: Vilija R Joyce; Tassos C Kyriakides; Mark Sculpher; Huiying Sun; Mike Youle; Aslam H Anis; Paul G Barnett; Ahmed M Bayoumi; Sheldon T Brown; D William Cameron; Adam Chow; Susan C Griffin; Mark Holodniy; Douglas K Owens
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial.
Medical decision making : an international journal of the Society for Medical Decision Making 2012;32(1):70-82.
2011: Joe L Hsu; Margaret Lin; Stephen J Ruoss; Natalie D Bower; Mark Holodniy; David A Stevens
Diagnosing invasive fungal disease in critically ill patients.
Critical reviews in microbiology 2011;37(4):277-312.
2011: Mark Winters; Sheldon Brown; Robert Lloyd; Azra Shahidi; Mark Holodniy
Use of dried clinical samples for storing and detecting influenza RNA.
Influenza and other respiratory viruses 2011;5(6):413-7.
2011: Aarthi Chary; Mark Holodniy
Interferon combination therapy for HIV/hepatitis C virus coinfection.
Immunotherapy 2011;3(9):1087-102.
2011: Paul G Barnett; Ahmed M Bayoumi; Sheldon T Brown; Adam Chow; Susan C Griffin; Mark Holodniy; Vilija R Joyce; Bohdan Nosyk; Aslam H Anis; Mark Sculpher; Douglas K Owens
Determinants of the cost of health services used by veterans with HIV.
Medical care 2011;49(9):848-56.
2011: Joe L Hsu; Andrew M Siroka; Mark W Smith; Mark Holodniy; G Umberto Meduri
One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2011;15(6):e382-7.
2011: Pannyun Yiu; Nancy N Nguyen; Mark Holodniy
Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy.
Pharmacotherapy 2011;31(5):480-9.
2011: Cynthia A Lucero; Frank Maldonado; Gina Oda; Richard Wojcik; Kenneth Cox; Joseph S. Lombardo; Mark Holodniy
Enhanced health event detection and influenza surveillance using a joint Veterans Affairs and Department of Defense biosurveillance application.
BMC medical informatics and decision making 2011;11():56.
2011: Mark Holodniy; Sheldon T Brown; D William Cameron; Tassos C Kyriakides; Brian Angus; Abdel Babiker; Joel Singer; Douglas K Owens; Aslam Anis; Ruth Goodall; Fleur Hudson; Mirek Piaseczny; John Russo; Martin Schechter; Lawrence Deyton; Janet Darbyshire
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.
PloS one 2011;6(3):e14764.
2010: Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori
Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2010;304(22):2485-93.
2010: David B Matchar; Alan Jacobson; Rowena J Dolor; Robert Edson; Lauren Uyeda; Ciaran S Phibbs; Julia E Vertrees; Mei-Chiung Shih; Mark Holodniy; Philip Lavori
Effect of home testing of international normalized ratio on clinical events.
The New England journal of medicine 2010;363(17):1608-20.
2010: Mark A Winters; Koen K A Van Rompay; Angela D M Kashuba; Nancy S Shulman; Mark Holodniy
Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques.
Antimicrobial agents and chemotherapy 2010;54(10):4059-63.
2010: Aarthi Chary; Mark A Winters; Shyam Kottilil; Alison A Murphy; Michael A Polis; Mark Holodniy
Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients.
The Journal of infectious diseases 2010;202(6):889-93.
2010: Aarthi Chary; Mark Holodniy
Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials.
Reviews on recent clinical trials 2010;5(3):158-73.
2010: Patricia Schirmer; Cybèle A Renault; Mark Holodniy
Is spinal tuberculosis contagious?
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2010;14(8):e659-66.
2010: Birgitt Dau; Dieter Ayers; Joel Singer; P Richard Harrigan; Sheldon Brown; Tassos Kyriakides; D William Cameron; Brian Angus; Mark Holodniy
Connection domain mutations in treatment-experienced patients in the OPTIMA trial.
Journal of acquired immune deficiency syndromes (1999) 2010;54(2):160-6.
2010: Mark A Winters; Aarthi Chary; Robert Eison; David M Asmuth; Mark Holodniy
Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.
Journal of medical virology 2010;82(5):791-8.
2010: Patricia Schirmer; Cynthia Lucero; Gina Oda; Jessica Lopez; Mark Holodniy
Effective detection of the 2009 H1N1 influenza pandemic in U.S. Veterans Affairs medical centers using a national electronic biosurveillance system.
PloS one 2010;5(3):e9533.
2010: Amanda J Snodgrass; Heather M Campbell; David L Mace; Victoria L Faria; Kathleen M Swanson; Mark Holodniy
Sudden sensorineural hearing loss associated with vardenafil.
Pharmacotherapy 2010;30(1):112.
2010: Gerardo C Palacios; Luz M Sanchez; Evangelina Briones; Teresa J Ramirez; Hugo Castillo; Lydia G Rivera; Carlos A Vazquez; Cristina Rodriguez-Padilla; Mark Holodniy
Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2010;14(1):e34-40.
2009: Bohdan Nosyk; Huiying Sun; Nick Bansback; Daphne P Guh; Xin Li; Paul Barnett; Ahmed Bayoumi; Susan Griffin; Vilija Joyce; Mark Holodniy; Doug K Owens; Aslam H Anis
The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(7):815-24.
2009: Aslam H Anis; Bohdan Nosyk; Huiying Sun; Daphne P Guh; Nick Bansback; Xin Li; Paul G Barnett; Vilija Joyce; Kathleen M Swanson; Tassos C Kyriakides; Mark Holodniy; William Cameron; Sheldon T Brown
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events.
Journal of acquired immune deficiency syndromes (1999) 2009;51(5):631-9.
2009: Dennis W Raisch; Timothy M Straight; Mark Holodniy
Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature.
Pharmacotherapy 2009;29(8):988-92.
2009: Patricia Schirmer; Mark Holodniy
Oseltamivir for treatment and prophylaxis of influenza infection.
Expert opinion on drug safety 2009;8(3):357-71.
2009: Birgitt Dau; Gina Oda; Mark Holodniy
Infectious complications in OIF/OEF veterans with traumatic brain injury.
Journal of rehabilitation research and development 2009;46(6):673-84.
2009: Vilija R Joyce; Paul G Barnett; Ahmed M Bayoumi; Susan C Griffin; Tassos C Kyriakides; Wei Yu; Vandana Sundaram; Mark Holodniy; Sheldon T Brown; William Cameron; Mike Youle; Mark J Sculpher; Aslam H Anis; Douglas K Owens
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
Journal of acquired immune deficiency syndromes (1999) 2009;50(1):27-36.
2009: Birgitt Dau; Mark Holodniy
Novel targets for antiretroviral therapy: clinical progress to date.
Drugs 2009;69(1):31-50.
2008: Mark Holodniy; Scott R Penzak; Timothy M Straight; Richard Davey; Kelvin K Lee; Matthew Bidwell Goetz; Dennis W Raisch; Francesca Cunningham; Emil T Lin; Noemi Olivo; Lawrence R Deyton
Pharmacokinetics and tolerability of oseltamivir combined with probenecid.
Antimicrobial agents and chemotherapy 2008;52(9):3013-21.
2008: Birgitt Dau; Mark Holodniy
The Relationship Between HIV Infection and Cardiovascular Disease.
Current cardiology reviews 2008;4(3):203-18.
2008: Gillian D Sanders; Ahmed M Bayoumi; Mark Holodniy; Douglas K Owens
Cost-effectiveness of HIV screening in patients older than 55 years of age.
Annals of internal medicine 2008;148(12):889-903.
2008: Ronald O Valdiserri; Fred Rodriguez; Mark Holodniy
Frequency of HIV screening in the Veterans Health Administration: implications for early diagnosis of HIV infection.
AIDS education and prevention : official publication of the International Society for AIDS Education 2008;20(3):258-64.
2008: Richard Davey; Peter E Pertel; Alice Benson; Delanie J Cassell; Brian G Gazzard; Mark Holodniy; Jacob P Lalezari; Yves Levy; Ronald T Mitsuyasu; Frank J Palella; Richard B Pollard; Prabhu Rajagopalan; Michael S Saag; Robert A Salata; Beverly E Sha; Shurjeel Choudhri
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2008;28(2):89-100.
2008: Janice K Louie; Adriana E Kajon; Mark Holodniy; Lilly Guardia-LaBar; Brian Lee; Ann M Petru; Jill K Hacker; David P Schnurr
Severe pneumonia due to adenovirus serotype 14: a new respiratory threat?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):421-5.
2008: Nancy Nguyen; Mark Holodniy
HIV infection in the elderly.
Clinical interventions in aging 2008;3(3):453-72.
2007: Douglas K Owens; Vandana Sundaram; Laura C Lazzeroni; Lena R Douglass; Gillian D Sanders; Kathie Taylor; Ronald VanGroningen; Vera M Shadle; Valerie C McWhorter; Teodora Agoncillo; Noreen Haren; Jill Nyland; Patricia Tempio; Walid Khayr; Dennis J Dietzen; Peter Jensen; Michael S Simberkoff; Samuel A Bozzette; Mark Holodniy
Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV.
American journal of public health 2007;97(12):2173-8.
2007: John Hornberger; Mark Holodniy; Katherine Robertus; Michael Winnike; Erin Gibson; Eric Verhulst
A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy.
Medical decision making : an international journal of the Society for Medical Decision Making 2007;27(6):789-821.
2007: Samit Desai; Tassos Kyriakides; Mark Holodniy; Jameela Al-Salman; Brigitte Griffith; Michael J Kozal
Evolution of genotypic resistance algorithms and their impact on the interpretation of clinical trials: an OPTIMA trial substudy.
HIV clinical trials 2007;8(5):293-302.
2007: Janet E Stout; Robert R Muder; Sue Mietzner; Marilyn M Wagener; Mary Beth Perri; Kathleen DeRoos; Dona Goodrich; William Arnold; Theresa Williamson; Ola Ruark; Christine Treadway; Elizabeth C Eckstein; Debra Marshall; Mary Ellen Rafferty; Kathleen Sarro; Joann Page; Robert Jenkins; Gina Oda; Kathleen J Shimoda; Marcus Zervos; Marvin Bittner; Sharon L Camhi; Anand P Panwalker; Curtis J Donskey; Minh-Hong Nguyen; Mark Holodniy; Victor L Yu
Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007;28(7):818-24.
2007: Douglas K Owens; Vandana Sundaram; Laura C Lazzeroni; Lena R Douglass; Patricia Tempio; Mark Holodniy; Gillian D Sanders; Vera M Shadle; Valerie C McWhorter; Teodora Agoncillo; Noreen Haren; Darlene Chavis; Leila H Borowsky; Elizabeth M Yano; Peter Jensen; Michael S Simberkoff; Samuel A Bozzette
HIV testing of at risk patients in a large integrated health care system.
Journal of general internal medicine 2007;22(3):315-20.
2007: Mark Holodniy
Darunavir in the treatment of HIV-1 infection: a viewpoint by Mark Holodniy.
Drugs 2007;67(18):2803.
2007: Mary A Banach; Bernard R Gifford; Mark Holodniy
Representational fluency in HIV clinical practice: a model of instructor discourse.
The Journal of continuing education in the health professions 2007;27(3):149-56.
2007: Zhuang Liu; Mark Winters; Mark Holodniy; Hongjie Dai
siRNA delivery into human T cells and primary cells with carbon-nanotube transporters.
Angewandte Chemie (International ed. in English) 2007;46(12):2023-7.
2007: Mark Holodniy; John Hornberger; Dana Rapoport; Katherine Robertus; Thomas E MaCurdy; Jude Lopez; Paul A Volberding; Lawrence Deyton
Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).
Journal of acquired immune deficiency syndromes (1999) 2007;44(1):20-9.
2006: Mark Holodniy
HIV-1 load quantitation: a 17-year perspective.
The Journal of infectious diseases 2006;194 Suppl 1():S38-44.
2006: Mark Holodniy
Prevention of shingles by varicella zoster virus vaccination.
Expert review of vaccines 2006;5(4):431-43.
2006: Mark A Winters; Seth Welles; Mark Holodniy
Hepatitis C virus protease gene diversity in patients coinfected with human immunodeficiency virus.
Journal of virology 2006;80(8):4196-9.
2006: Shyoko Honiden; Vandana Sundaram; Robert F Nease; Mark Holodniy; Laura C Lazzeroni; Andrew R Zolopa; Douglas K Owens
The effect of diagnosis with HIV infection on health-related quality of Life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(1):69-82.
2006: Minghsun Liu; Mark Holodniy; Andrew R Zolopa; Robert W Shafer
Case files from Stanford University Medical Center: the initial presentation of HIV-1 infection--where public and personal health meet.
MedGenMed : Medscape general medicine 2006;8(1):24.
2006: Michael Borucki; Mark Holodniy; Gerald Pierone; Peter Ruane; Corklin R Steinhart; Sally Williams; Trevor Slom; Frank J Palella; C Bradley Hare; Yasuhisa Yoshidao; Xiao-Dong Li; Richard B Pollard
The safety and tolerability of Z-100 in patients infected with HIV-1.
Antiviral therapy 2006;11(3):297-303.
2006: Matthew Bidwell Goetz; Mark Holodniy; June S Poulton; Fred H Rodriguez; Michael O Rigsby
Utilization and access to antiretroviral genotypic resistance testing and results within the US Department of Veterans Affairs.
Journal of acquired immune deficiency syndromes (1999) 2006;41(1):59-62.
2005: Norah A Terrault; J-M Pawlotsky; J McHutchison; F Anderson; Mel Krajden; Stuart Gordon; IM Zitron; Robert P Perrillo; R Gish; Mark Holodniy; Michel Friesenhahn
Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.
Journal of viral hepatitis 2005;12(5):465-72.
2005: Andrew R Zolopa; Laura C Lazzeroni; Alex Rinehart; Françoise Brun Vezinet; François Clavel; Ann Collier; Brian Conway; Roy M Gulick; Mark Holodniy; Carlo-Frederico Perno; Robert W Shafer; Douglas D Richman; Mark A Wainberg; Daniel R Kuritzkes
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(1):92-9.
2005: Karen I Relucio; Hans T Beernink; Donna Chen; Dennis Israelski; Raymond Kim; Mark Holodniy
Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART).
Journal of proteome research 2005;4(2):227-31.
2005: Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
The New England journal of medicine 2005;352(6):570-85.
2004: Mark Holodniy; Edwin D Charlebois; david bangsberg; Andrew R Zolopa; M Schulte; Andrew R Moss
Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study.
International journal of STD & AIDS 2004;15(8):543-51.
2004: Tarek Elbeik; Johan Surtihadi; Mark Destree; Jed Gorlin; Mark Holodniy; Saeed A Jortani; Ken Kuramoto; Valerie Ng; Roland Valdes; Alexandra Valsamakis; Norah A Terrault
Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
Journal of clinical microbiology 2004;42(2):563-9.
2003: Theresa L-Y Chang; Chia-Hwa Chang; David A Simpson; Qiang Xu; Patrick K Martin; Laurel A Lagenaur; Gary K Schoolnik; David D Ho; Sharon L Hillier; Mark Holodniy; John A Lewicki; Peter P Lee
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11672-7.
2003: david bangsberg; Edwin D Charlebois; Robert M Grant; Mark Holodniy; Steven G Deeks; Sharon Perry; Kathleen Nugent Conroy; Richard Clark; David Guzman; Andrew R Zolopa; Andrew Moss
High levels of adherence do not prevent accumulation of HIV drug resistance mutations.
AIDS (London, England) 2003;17(13):1925-32.
2003: Tassos C Kyriakides; Abdel Babiker; Joel Singer; William Cameron; Martin T Schechter; Mark Holodniy; Sheldon Brown; Mike Youle; Brian Gazzard
An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial.
Controlled clinical trials 2003;24(4):481-500.
2003: Robert M Grant; Daniel R Kuritzkes; Victoria A Johnson; John W Mellors; John L Sullivan; Ronald Swanstrom; Richard T D'Aquila; Mark Van Gorder; Mark Holodniy; Robert M Lloyd Jr; Caroline Reid; Gillian F Morgan; Dean L Winslow
Accuracy of the TRUGENE HIV-1 genotyping kit.
Journal of clinical microbiology 2003;41(4):1586-93.
2003: Fred A Lopez; Frances Johnson; Denise M Novosad; Blaine L Beaman; Mark Holodniy
Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2003;22(4):492-7.
2003: Jennifer M Babik; Mark Holodniy
Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.
Journal of virology 2003;77(3):1940-50.
2002: Karen Relucio; Mark Holodniy
HIV-1 RNA and viral load.
Clinics in laboratory medicine 2002;22(3):593-610.
2000: M Fujinaga; M Schulte; Mark Holodniy
Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture system.
Teratology 2000;62(2):108-14.
2000: david bangsberg; Frederick Hecht; Edwin D Charlebois; Andrew R Zolopa; Mark Holodniy; L Sheiner; Joshua D Bamberger; Margaret A Chesney; Andrew Moss
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
AIDS (London, England) 2000;14(4):357-66.
2000: Mark Holodniy; L Rainen; S Herman; B Yen-Lieberman
Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment.
Journal of clinical microbiology 2000;38(1):323-6.
1999: Mark Holodniy; J Koch; M Mistal; J M Schmidt; A Khandwala; J E Pennington; S B Porter
A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
The American journal of gastroenterology 1999;94(11):3267-73.
1999: Mark Holodniy
Effects of collection, processing, and storage on RNA detection and quantification.
Methods in molecular medicine 1999;26():43-59.
1998: Mark Holodniy
Phenotypic and genotypic testing in clinical practice.
AIDS patient care and STDs 1998;12(7):527-31.
1998: Mark Holodniy; D Anderson; D Wright; O Sharma; Jonathan A Cohn; N Alexander; P Stratton; P Reichelderferd
HIV quantitation in spiked vaginocervical secretions: lack of non-specific inhibitory factors. DATRI 005 Study Team. Division of AIDS Treatment Research Initiative.
Journal of virological methods 1998;72(2):185-95.
1997: Steven G Deeks; M Smith; Mark Holodniy; James O Kahn
HIV-1 protease inhibitors. A review for clinicians.
JAMA : the journal of the American Medical Association 1997;277(2):145-53.
1996: R L Kline; D McNairn; Mark Holodniy; L Mole; D Margolis; William A Blattner; Thomas C Quinn
Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay.
Journal of clinical microbiology 1996;34(11):2650-3.
1996: Mark Holodniy; David Katzenstein; L Mole; M Winters; Thomas C Merigan
Human immunodeficiency virus reverse transcriptase codon 215 mutations diminish virologic response to didanosine-zidovudine therapy in subjects with non-syncytium-inducing phenotype.
The Journal of infectious diseases 1996;174(4):854-7.
1996: OJ Cohen; Giuseppe Pantaleo; Mark Holodniy; CH Fox; Jan M Orenstein; SM Schnittman; M Niu; C Graziosi; George Pavlakis; J Lalezari; J A Bartlett; R T Steigbigel; Jonathan A Cohn; Richard M Novak; D McMahon; John Bilello; Anthony Fauci
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.
The Journal of infectious diseases 1996;173(4):849-56.
1996: Mark Holodniy; D Margolis; R Carroll; J Todd; L Mole
Quantitative relationship between platelet count and plasma virion HIV RNA.
AIDS (London, England) 1996;10(2):232-3.
1995: P S Eastman; E Boyer; L Mole; Janice A Kolberg; MS Urdea; Mark Holodniy
Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.
Journal of clinical microbiology 1995;33(10):2777-80.
1995: Ann C Collier; Robert W Coombs; David Katzenstein; Mark Holodniy; J Gibson; J Mordenti; Allen E Izu; AM Duliege; A J Ammann; T Merigan
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(2):150-6.
1995: OJ Cohen; Giuseppe Pantaleo; Mark Holodniy; SM Schnittman; M Niu; C Graziosi; George Pavlakis; J Lalezari; J A Bartlett; R T Steigbigel
Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(13):6017-21.
1995: Mark Holodniy; L Mole; D Margolis; J Moss; H Dong; E Boyer; MS Urdea; Janice A Kolberg; S Eastman
Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy.
Journal of virology 1995;69(6):3510-6.
1995: Mark Holodniy; L Mole; Belinda Yen-Lieberman; D Margolis; C Starkey; R Carroll; T Spahlinger; J Todd; J Brooks Jackson
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.
Journal of clinical microbiology 1995;33(6):1562-6.
1995: David A Katzenstein; Mark Holodniy
HIV viral load quantification, HIV resistance, and antiretroviral therapy.
AIDS clinical review 1995;():277-303.
1994: Lucy Rasmussen; S Morris; R Wolitz; A Dowling; J Fessell; Mark Holodniy; Thomas C Merigan
Deficiency in antibody response to human cytomegalovirus glycoprotein gH in human immunodeficiency virus-infected patients at risk for cytomegalovirus retinitis.
The Journal of infectious diseases 1994;170(3):673-7.
1994: L Mole; D Margolis; R Carroll; J Todd; Mark Holodniy
Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.
Journal of clinical microbiology 1994;32(9):2212-5.
1994: L Mole; D Margolis; L Ghotbi; Mark Holodniy
The use of pentoxifylline alone in HIV-infected patients.
Journal of acquired immune deficiency syndromes 1994;7(5):519-21.
1994: Mark Holodniy; L Mole; M Winters; Thomas C Merigan
Diurnal and short-term stability of HIV virus load as measured by gene amplification.
Journal of acquired immune deficiency syndromes 1994;7(4):363-8.
1993: K A Hamed; M A Winters; Mark Holodniy; David A Katzenstein; Thomas C Merigan
Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy.
The Journal of infectious diseases 1993;167(4):798-802.
1993: Mark Holodniy; David Katzenstein; M Winters; J Montoya; R Shafer; M Kozal; M Ragni; Thomas C Merigan
Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.
Journal of acquired immune deficiency syndromes 1993;6(4):366-9.
1992: M A Winters; Mark Holodniy; David A Katzenstein; Thomas C Merigan
Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
PCR methods and applications 1992;1(4):257-62.
1992: J Mohle-Boetani; S K Akula; Mark Holodniy; David Katzenstein; G Garcia
The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.
The Western journal of medicine 1992;156(3):303-6.
1992: W Blumenfeld; O McCook; Mark Holodniy; D A Katzenstein
Correlation of morphologic diagnosis of Pneumocystis carinii with the presence of pneumocystis DNA amplified by the polymerase chain reaction.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(2):103-6.
1992: A G Clark; Mark Holodniy; David H Schwartz; David A Katzenstein; Thomas C Merigan
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration.
Journal of acquired immune deficiency syndromes 1992;5(1):52-9.
1992: David A Katzenstein; Mark Holodniy; D M Israelski; S Sengupta; L A Mole; J L Bubp; Thomas C Merigan
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment.
Journal of acquired immune deficiency syndromes 1992;5(2):107-12.
1992: Mark Holodniy; M A Winters; Thomas C Merigan
Detection and quantification of gene amplification products by a nonisotopic automated system.
BioTechniques 1992;12(1):36, 38-9.
1992: David A Katzenstein; Mark Holodniy
Quantitative virological measures of antiretroviral therapy.
AIDS clinical review 1992;():41-67.
1991: Mark Holodniy; David A Katzenstein; D M Israelski; Thomas C Merigan
Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.
The Journal of clinical investigation 1991;88(5):1755-9.
1991: Jonathan Mermin; Mark Holodniy; David A Katzenstein; Thomas C Merigan
Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction.
The Journal of infectious diseases 1991;164(4):769-72.
1991: Mark Holodniy; David A Katzenstein; S Sengupta; A M Wang; C Casipit; David H Schwartz; M Konrad; E Groves; Thomas C Merigan
Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction.
The Journal of infectious diseases 1991;163(4):862-6.
1991: Mark Holodniy; S Kim; David Katzenstein; M Konrad; E Groves; Thomas C Merigan
Inhibition of human immunodeficiency virus gene amplification by heparin.
Journal of clinical microbiology 1991;29(4):676-9.
1991: Mark Holodniy; J Almenoff; J Loutit; G K Steinberg
Cerebral sparganosis: case report and review.
Reviews of infectious diseases 1991;13(1):155-9.